To further explore the role of SLC2A1 as a prognostic biomarker in cancer, we analyzed TCGA Pan-Cancer survival data, including OS, DFS, disease-specific survival (DSS), and progression-free survival (PFS), and presented the results in the form of a forest diagram. The gene discussed is SLC2A1; the disease is cancer.